Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | 25.5 | 16.6 | 37.4 | 9.72 | 13.9 | 5.69 | |||
Changes by years, y/y, % | +191% | -35% | +126% | -74% | +43% | +9.6% |
Teva Pharmaceutical Industries. P/FCF
Teva Pharmaceutical Industries. P/FCF, changes, %
Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
P/FCF | 7.19 | 18.8 | 11.0 | 13.9 | 13.5 | 5.69 | ||
Changes by years, y/y, % | -59% | +8% | +13% | +43% | +32% | |||
Changes by quarters, q/q, % | -30% | +162% | -42% | +26% | -3% |